Publications by authors named "Sara Chami-Pena"
Background: One aspect of the distancing measures imposed in response to the COVID-19 pandemic is that telemedicine consultations have increased exponentially. Among these consultations, the assessment and follow-up of patients with chronic diseases in a non-presential setting has been strengthened considerably. Nevertheless, some controversy remains about the most suitable means of patient follow-up.
View Article and Find Full Text PDFArticle Synopsis
- ACE inhibitors (ACEIs) and angiotensin receptor antagonists (ARAIIs) are commonly used to treat high blood pressure, but their effects on chronic COVID-19 patients are debated.
- A systematic review analyzed data from multiple databases, examining articles related to hypertension in older adults during the COVID-19 pandemic.
- Results show mixed findings on the impact of ACEIs and ARAIIs, with some studies suggesting a protective effect against COVID-19 while others indicate risk, but overall, there is no strong evidence against their continued use in hypertensive patients during COVID-19.
Background: B cells are central to the pathogenesis of systemic lupus erythematosus (SLE). We aimed to analyze the efficacy and safety of new B cell-targeted drug therapies for SLE.
Methods: A systematic review of randomized controlled trials (RCTs) and reference lists of relevant articles published from inception to 2022 were selected from PubMed, Scopus and Web of Science databases.